Riskpilot← Back to searchSign inGet full accessMedConsult A Steen AB
ABActiveOrg 5569796856Högklintsvägen 17Hospital activities · NACE 8610Est. 20141 employees
Revenue 2024
SEK 629K
-39% vs 2023
EBITDA margin
24.6%
-29% vs 2023
Equity ratio
62.5%
Financial strength
Net profit 2024
SEK 111K
-34% vs 2023
| Revenue | SEK 629K | -39% |
| EBITDA | SEK 155K | -29% |
| Net profit | SEK 111K | -34% |
| Total assets | SEK 400K | -11% |
| Equity | SEK 250K | +80% |
| Employees | 1 | — |
Legal name
MedConsult A Steen AB
Org number
5569796856
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
18 augusti 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget skall bedriva medicinsk konsultverksamhet och handel och förvaltning av värdepapper samt därmed förenlig verksamhet.
Address
Högklintsvägen 17
Email
andrejsteen@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 863 | 968 | 898 | 1 024 | 629 |
| Staff expenses | — | — | — | — | −175 |
| EBITDA | 3 | 249 | 30 | 219 | 155 |
| Depreciation & amort. | −11 | −0 | −9 | −9 | −9 |
| EBIT | −8 | 249 | 21 | 210 | 146 |
| Net financials | — | — | 25 | 1 | −5 |
| Profit before tax | −8 | 249 | 46 | 211 | 141 |
| Tax | −0 | −51 | −4 | −43 | −30 |
| Net profit | −8 | 198 | 42 | 168 | 111 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 600 | 872 | 433 | 448 | 400 |
| Equity | 362 | 559 | 181 | 139 | 250 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 239 | 312 | 251 | 309 | 150 |
| Total debt | 239 | 312 | 251 | 309 | 150 |
EBITDA margin
24.6%
This company
15.8%
Market median
+56% vs market
20202024
Equity ratio
62.5%
This company
38.2%
Market median
+64% vs market
20202024
Return on equity
44.4%
This company
18.4%
Market median
+141% vs market
20202024
Net profit margin
17.7%
This company
8.1%
Market median
+119% vs market
20202024
Asset turnover
1.57×
This company
1.12×
Market median
+40% vs market
20202024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedConsult A Steen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sanela Steen | Board of Directors | 0 companies |
| Andrej Karl Dubravko Steen | Chairman | 0 companies |
| Toni Lazarevski | Deputy Board Member | 0 companies |